OncologyPRO | Educational Portal for Oncologists...patients with advanced NETS after progression on...
27
OncologyPRO | Educational Portal for Oncologists...patients with advanced NETS after progression on everolimus N 395 Well- or moderately-differentiated neuroendocrine Cabozantinib